NCT05099471 - Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2033

Conditions

Waldenstrom MacroglobulinemiaTreatment Naive

Interventions

DRUG

Venetoclax; Rituximab

Combination of venetoclax and rituximab

DRUG

DRC

Combination of Dexamethasone / Rituximab / Cyclophosphamide

Trial Locations (11)

24105

NOT_YET_RECRUITING

Universitaetsklinikum Schleswig-Holstein AöR, Kiel

33604

NOT_YET_RECRUITING

Onkologische Schwerpunktpraxis Bielefeld, Bielefeld

41063

NOT_YET_RECRUITING

Kliniken Maria Hilf GmbH Moenchengladbach, Mönchengladbach

48149

NOT_YET_RECRUITING

Universitaet Muenster, Münster

56073

NOT_YET_RECRUITING

Gemeinschaftsklinikum Mittelrhein gGmbH, Koblenz

81241

RECRUITING

Haematologie und Onkologie Muenchen-Pasing MVZ GmbH, München

84036

NOT_YET_RECRUITING

Dr. Vehling-Kaiser MVZ GmbH, Landshut

87439

NOT_YET_RECRUITING

Klinikverbund Allgaeu gGmbH, Kempten (Allgäu)

89081

RECRUITING

University Hospital Ulm, Ulm

09116

NOT_YET_RECRUITING

Klinikum Chemnitz gGmbH, Chemnitz

115 28

NOT_YET_RECRUITING

Alexandra Hospital, Athens